257 related articles for article (PubMed ID: 23890219)
1. Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells.
Xiang T; Li L; Yin X; Zhong L; Peng W; Qiu Z; Ren G; Tao Q
J Cell Mol Med; 2013 Oct; 17(10):1236-46. PubMed ID: 23890219
[TBL] [Abstract][Full Text] [Related]
2. DKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell.
Guo Q; Qin W
J Cell Mol Med; 2015 Dec; 19(12):2832-41. PubMed ID: 26395974
[TBL] [Abstract][Full Text] [Related]
3. Dickkopf-related protein 2 induces G0/G1 arrest and apoptosis through suppressing Wnt/β-catenin signaling and is frequently methylated in breast cancer.
Mu J; Hui T; Shao B; Li L; Du Z; Lu L; Ye L; Li S; Li Q; Xiao Q; Qiu Z; Zhang Y; Fan J; Ren G; Tao Q; Xiang T
Oncotarget; 2017 Jun; 8(24):39443-39459. PubMed ID: 28467796
[TBL] [Abstract][Full Text] [Related]
4. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
5. Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3.
Shailesh H; Siveen KS; Sif S
J Cell Mol Med; 2021 Feb; 25(3):1583-1600. PubMed ID: 33462997
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer.
Veeck J; Wild PJ; Fuchs T; Schüffler PJ; Hartmann A; Knüchel R; Dahl E
BMC Cancer; 2009 Jul; 9():217. PubMed ID: 19570204
[TBL] [Abstract][Full Text] [Related]
7. Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers.
Yang ZQ; Liu G; Bollig-Fischer A; Haddad R; Tarca AL; Ethier SP
Int J Cancer; 2009 Oct; 125(7):1613-21. PubMed ID: 19569235
[TBL] [Abstract][Full Text] [Related]
8. DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer.
Yin X; Xiang T; Li L; Su X; Shu X; Luo X; Huang J; Yuan Y; Peng W; Oberst M; Kelly K; Ren G; Tao Q
Breast Cancer Res; 2013 Mar; 15(2):R23. PubMed ID: 23497530
[TBL] [Abstract][Full Text] [Related]
9. Dickkopf-Related Protein 2 is Epigenetically Inactivated and Suppresses Colorectal Cancer Growth and Tumor Metastasis by Antagonizing Wnt/β-Catenin Signaling.
Wang C; Yue Y; Shao B; Qiu Z; Mu J; Tang J; Han X; Xiang T; Ren G
Cell Physiol Biochem; 2017; 41(5):1709-1724. PubMed ID: 28365691
[TBL] [Abstract][Full Text] [Related]
10. Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors.
Sato H; Suzuki H; Toyota M; Nojima M; Maruyama R; Sasaki S; Takagi H; Sogabe Y; Sasaki Y; Idogawa M; Sonoda T; Mori M; Imai K; Tokino T; Shinomura Y
Carcinogenesis; 2007 Dec; 28(12):2459-66. PubMed ID: 17675336
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma.
Kaur P; Mani S; Cros MP; Scoazec JY; Chemin I; Hainaut P; Herceg Z
Tumour Biol; 2012 Apr; 33(2):325-36. PubMed ID: 22351518
[TBL] [Abstract][Full Text] [Related]
12. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells.
Xiang T; Fan Y; Li C; Li L; Ying Y; Mu J; Peng W; Feng Y; Oberst M; Kelly K; Ren G; Tao Q
Oncotarget; 2016 Oct; 7(43):70924-70935. PubMed ID: 27708215
[TBL] [Abstract][Full Text] [Related]
13. MYCN is a novel oncogenic target in adult B-ALL that activates the Wnt/β-catenin pathway by suppressing DKK3.
Kong D; Zhao L; Sun L; Fan S; Li H; Zhao Y; Guo Z; Lin L; Cui L; Wang K; Chen W; Zhang Y; Zhou J; Li Y
J Cell Mol Med; 2018 Jul; 22(7):3627-3637. PubMed ID: 29673070
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer.
Yue W; Sun Q; Dacic S; Landreneau RJ; Siegfried JM; Yu J; Zhang L
Carcinogenesis; 2008 Jan; 29(1):84-92. PubMed ID: 18048388
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor interferon regulatory factor 8 inhibits β-catenin signaling in breast cancers, but is frequently silenced by promoter methylation.
Luo X; Xiong X; Shao Q; Xiang T; Li L; Yin X; Li X; Tao Q; Ren G
Oncotarget; 2017 Jul; 8(30):48875-48888. PubMed ID: 28388578
[TBL] [Abstract][Full Text] [Related]
16. HCV Core protein represses DKK3 expression via epigenetic silencing and activates the Wnt/β-catenin signaling pathway during the progression of HCC.
Wang X; Zhou Y; Wang C; Zhao Y; Cheng Y; Yu S; Li X; Zhang W; Zhang Y; Quan H
Clin Transl Oncol; 2022 Oct; 24(10):1998-2009. PubMed ID: 35768685
[TBL] [Abstract][Full Text] [Related]
17. Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer.
Suzuki H; Toyota M; Carraway H; Gabrielson E; Ohmura T; Fujikane T; Nishikawa N; Sogabe Y; Nojima M; Sonoda T; Mori M; Hirata K; Imai K; Shinomura Y; Baylin SB; Tokino T
Br J Cancer; 2008 Mar; 98(6):1147-56. PubMed ID: 18283316
[TBL] [Abstract][Full Text] [Related]
18. Pax6 regulates the expression of Dkk3 in murine and human cell lines, and altered responses to Wnt signaling are shown in FlpIn-3T3 cells stably expressing either the Pax6 or the Pax6(5a) isoform.
Forsdahl S; Kiselev Y; Hogseth R; Mjelle JE; Mikkola I
PLoS One; 2014; 9(7):e102559. PubMed ID: 25029272
[TBL] [Abstract][Full Text] [Related]
19. MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway.
Li Q; Shen K; Zhao Y; Ma C; Liu J; Ma J
J Transl Med; 2013 Dec; 11():302. PubMed ID: 24325785
[TBL] [Abstract][Full Text] [Related]
20. Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.
Moskalev EA; Luckert K; Vorobjev IA; Mastitsky SE; Gladkikh AA; Stephan A; Schrenk M; Kaplanov KD; Kalashnikova OB; Pötz O; Joos TO; Hoheisel JD
BMC Cancer; 2012 Jun; 12():213. PubMed ID: 22672427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]